Barclays analyst Luke Sergott initiates coverage on Repligen (NASDAQ: RGEN) with a Overweight rating and a price target of $150.00.The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE